Highlights
NASDAQ: CBAY       Cymabay Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
9.03   +0.26 (2.96%)  8.61 - 9.06  763,100

Overview

 
Avg Volume (4 weeks):1,492,270
4 Weeks Range:6.13 - 9.06
4 Weeks Price Volatility (%):
98.98%
52 Weeks Range:1.21 - 9.06
52 Weeks Price Volatility (%):
99.62%
Average Price Target: 15.00
Price Target Upside/Downside: +5.97

Headlines



No recent Headlines for this stock.


Business Background

CymaBay Therapeutics Inc is a part of the healthcare sector based in the United States. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral, G-protein coupled receptor agonist being evaluated as a therapeutic agent for patients with Type 2 diabetes and MBX-8025 is a selective agonist for the peroxisome proliferator-activated receptor delta.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4328  4069  664  210 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 43.17+4.20 
 SCKT 2.55+1.09 
 GE 7.63-0.09 
 INTC 48.20-5.70 
 AAL 12.60-0.55 
 MRIN 3.45+1.33 
 AAPL 115.04-0.71 
 OAS 0.155-0.014 
 F 8.16-0.05 
 NIO 27.16-0.22